Top

Published in:

01-08-2011 | Short Communication

Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden

Authors: Seyed Mohsen Mousavi, Jan Sundquist, Kari Hemminki

Published in: Gastric Cancer | Issue 3/2011

Abstract

The observed increased risks of gastric cancer among first-generation immigrants compared to those in Swedes suggest the role of childhood environmental exposure in the risk of this disease.

Boyle P, Levin B. World Cancer Report 2008. Lyon: IARC; 2008.

GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 10 (Internet). (database on the Internet). International Agency for Research on Cancer. 2010 (cited 2010). Available from: http://globocan.iarc.fr.

Mousavi SM, Brant A, Sundquist J, Hemminki K. Esophageal cancer risk among immigrants in Sweden. Eur J Cancer Prev. 2011;20(2):71–6.CrossRefPubMed

Falk GW. Risk factors for esophageal cancer development. Surg Oncol Clin N Am. 2009;18(3):469–85.CrossRefPubMed

Lee J, Demissie K, Lu SE, Rhoads GG. Cancer incidence among Korean-American immigrants in the United States and native Koreans in South Korea. Cancer Control. 2007;14(1):78–85.PubMed

Tsugane S, de Souza JM, Costa ML Jr, Mirra AP, Gotlieb SL, Laurenti R, et al. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969–78. Cancer Causes Control. 1990;1(2):189–93.CrossRefPubMed

Kamineni A, Williams MA, Schwartz SM, Cook LS, Weiss NS. The incidence of gastric carcinoma in Asian migrants to the United States and their descendants. Cancer Causes Control. 1999;10(1):77–83.CrossRefPubMed

Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish family-cancer database 2009: Prospects for histology-specific and immigrant studies. Int J Cancer. 2009.

Hemminki K, Li XJ, Czene K. Cancer risks in first-generation immigrants to Sweden. Int J Cancer. 2002;99(2):218–28.CrossRefPubMed

10.

Hemminki K, Li X. Cancer risks in Nordic immigrants and their offspring in Sweden. Eur J Cancer. 2002;38(18):2428–34.CrossRefPubMed

11.

Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol. 2007;18(3):581–92.CrossRefPubMed

12.

Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries, Version 3.6. Association of the Nordic Cancer Registries. Danish Cancer Society (http://www.ancr.nu). (cited Jan. 2010); Available from: http://www-dep.iarc.fr/NORDCAN/english/frame.asp.

13.

Moradi T, Delfino RJ, Bergstrom SR, Yu ES, Adami HO, Yuen J. Cancer risk among Scandinavian immigrants in the US and Scandinavian residents compared with US whites, 1973–89. Eur J Cancer Prev. 1998;7(2):117–25.PubMed

14.

Nilsson B, Gustavson-Kadaka E, Rotstein S, Hakulinen T, Rahu M, Aareleid T. Cancer incidence in Estonian migrants to Sweden. Int J Cancer. 1993;55(2):190–5.CrossRefPubMed

15.

Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347(15):1175–86.CrossRefPubMed

Title: Does immigration play a role in the risk of gastric cancer by site and by histological type? A study of first-generation immigrants in Sweden
Authors: Seyed Mohsen Mousavi
Jan Sundquist
Kari Hemminki
Publication date: 01-08-2011
Publisher: Springer Japan
Published in: Gastric Cancer / Issue 3/2011
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI: https://doi.org/10.1007/s10120-011-0033-5

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2011

Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum

Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2

Increased risk of tuberculosis after gastrectomy and chemotherapy in gastric cancer: a 7-year cohort study

Negative trial results are important to understand the mechanisms of multimodality therapy in gastric cancer

IL-6 serum levels predict postoperative morbidity in gastric cancer patients

Erratum to: p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials